摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

deutero 2-(diphenylphosphino)benzaldehyde | 1394246-13-9

中文名称
——
中文别名
——
英文名称
deutero 2-(diphenylphosphino)benzaldehyde
英文别名
——
deutero 2-(diphenylphosphino)benzaldehyde化学式
CAS
1394246-13-9
化学式
C19H15OP
mdl
——
分子量
291.293
InChiKey
DRCPJRZHAJMWOU-RWFJLFJASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.26
  • 重原子数:
    21.0
  • 可旋转键数:
    4.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    17.07
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

反应信息

  • 作为反应物:
    描述:
    deutero 2-(diphenylphosphino)benzaldehyde(2-溴苯基)二苯基膦正丁基锂 作用下, 以 乙醚正己烷 为溶剂, 反应 0.5h, 以20%的产率得到
    参考文献:
    名称:
    通过铑α-羟烷基烷基络合物的聚合(De)加氢途径
    摘要:
    We report the convergent reaction pathways between [RhH(PPh3)4] and POP ketone (1) and alcohol (2) ligands that terminate in the formation of an alpha-hydroxylalkyl rhodium(I) complex (3), representing two halves of a formal reduction/oxidation pathway between 1 and 2. In the case of hydride transfer to 1, the formation of the a-hydroxylalkyl rhodium(I) complex (3) proceeds via a rare hydrido(eta(2)-carbonyl) complex (4). CH activation in 2 at the proligands central methine position, rather than OH activation of the hydroxy motif, followed by loss of dihydrogen also generates the alpha-hydroxylalkyl rhodium(I) complex (3). The validity of the postulated reaction pathways is probed with DFT calculations. The observed reactivity supports a-hydroxylalkyl complexes as competent intermediates in ketone hydrogenation catalyzed by rhodium hydrides and suggest that ligands 1 and 2 may be noninnocent coligands in reported hydrogenation catalyst systems in which they are utilized.
    DOI:
    10.1021/acs.organomet.7b00158
  • 作为产物:
    描述:
    N,N-二甲基甲酰胺-d7(2-溴苯基)二苯基膦正丁基锂 作用下, 以 乙醚正己烷 为溶剂, 反应 0.5h, 以52%的产率得到deutero 2-(diphenylphosphino)benzaldehyde
    参考文献:
    名称:
    通过铑α-羟烷基烷基络合物的聚合(De)加氢途径
    摘要:
    We report the convergent reaction pathways between [RhH(PPh3)4] and POP ketone (1) and alcohol (2) ligands that terminate in the formation of an alpha-hydroxylalkyl rhodium(I) complex (3), representing two halves of a formal reduction/oxidation pathway between 1 and 2. In the case of hydride transfer to 1, the formation of the a-hydroxylalkyl rhodium(I) complex (3) proceeds via a rare hydrido(eta(2)-carbonyl) complex (4). CH activation in 2 at the proligands central methine position, rather than OH activation of the hydroxy motif, followed by loss of dihydrogen also generates the alpha-hydroxylalkyl rhodium(I) complex (3). The validity of the postulated reaction pathways is probed with DFT calculations. The observed reactivity supports a-hydroxylalkyl complexes as competent intermediates in ketone hydrogenation catalyzed by rhodium hydrides and suggest that ligands 1 and 2 may be noninnocent coligands in reported hydrogenation catalyst systems in which they are utilized.
    DOI:
    10.1021/acs.organomet.7b00158
点击查看最新优质反应信息

文献信息

  • <i>C</i><sub>2</sub>-Symmetric Iron(II) Diphosphine–Dialkoxide Dicarbonyl and Related Complexes
    作者:Hao Lei、Aaron M. Royer、Thomas B. Rauchfuss、Danielle Gray
    DOI:10.1021/om300631a
    日期:2012.9.10
    adduct Fe(PCHO)(CO)4 (2), which was obtained by addition of PCHO to Fe2(CO)9. Compound 2 decarbonylates to give tricarbonyl Fe(κ1,η2-PCHO)(CO)3 (3), which features a π-bonded aldehyde. Photolysis of 2 gives a mixture of 3 and isomeric hydride HFe(κ2-PCO)(CO)3. Complex 3 reacts with an additional equivalent of PCHO to afford 1, whereas treatment with PPh3 afforded the substituted product Fe(κ1,η2-PCHO)(PPh3)(CO)2
    Fe(bda)(CO)3(bda =苄叉基丙酮)与Ph 2 P-2-C 6 H 4 CHO(PCHO)反应,制得双膦双醇盐配合物Fe [(Ph 2 PC 6 H 4)2 C 2 H 2 O 2 ](CO)2(1)由两个甲酰基与Fe(0)氧化为Fe(II)的头对头偶联而产生。晶体学研究表明1具有反式转化为CO的顺式烷氧基配体。两个膦基是相互反式的P–Fe–P角度为167.44(4)°。从加合物Fe(PCHO)(CO)4(2)开始检查通向1的途径,该加合物是通过将PCHO加到Fe 2(CO)9中获得的。化合物2 decarbonylates,得到三羰基铁(κ 1,η 2 -PCHO)(CO)3(3),其特点是π键合的醛。的光解2给出的混合物3和异构体氢化HFE(κ 2 -PCO)(CO)3。配合物3与另外等价的PCHO反应生成1,而用PPH治疗3,得到取代产物的Fe(κ 1,η 2 -PCHO)(PPH
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫